Results for the substance mirdametinib:

L01EE05 - mirdametinib (Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Mitogen-activated protein kinase (MEK) inhibitors)


OTHER MEDICINAL INFORMATION

CERTICAN 0.25mg tablets EUROPHARM everolimus antineoplastic agents, mammalian target of rapamycin (mtor) kinase inhibitors
LEVOFLOXACINA BLUEFISH 500mg film-coated tablets levofloxacin antibacterials for systemic use, fluoroquinolones
DUTILOX 30mg gastro-resistant capsules TOWA PHARMACEUTICAL duloxetine psychoanaleptics, other antidepressants
OGIVRI 420mg powder for concentrate infusion solution BIOSIMILAR COLLABORA trastuzumab antineoplastic agents, her2 (human epidermal growth factor receptor 2) inhibitors
LACTULOSE AL 66.7% syrup ALIUD lactulose drugs for constipation, osmotically acting laxatives
VENTOLIN 2mg/5ml syrup GLAXO SMITH KLINE salbutamol drugs for obstructive airway diseases, selective beta-2-adrenoreceptor agonists
LENALIDOMIDA GRINDEKS 5mg capsules AS GRINDEKS lenalidomide immunosuppressants, other immunosuppressants
OSELTAMIVIR LAROPHARM 30mg capsules oseltamivir antivirals for systemic use, neuraminidase inhibitors
PEMETREXED STADA 25mg/ml concentrate for solution for infusion pemetrexeda antineoplastic agents, folic acid analogues
BIODACYNA 1g/4ml solution for injection UNIFARM amikacin antibacterials for systemic use, other aminoglycosides
SOLUTIE RINGER HELVETICA solution for infusion BRAUN electrolytes blood substitutes and perfusion solutions, solutions affecting the electrolyte balance
NILEFRIN 5% ophthalmic drops solution TERAPIA phenylephrine ophthalmologicals, sympathomimetics excl. antiglaucoma preparations